WT Wealth Management Acquires New Shares in Docusign Inc. $DOCU

WT Wealth Management bought a new position in Docusign Inc. (NASDAQ:DOCUFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 20,734 shares of the company’s stock, valued at approximately $1,615,000.

A number of other hedge funds have also added to or reduced their stakes in DOCU. Banque Transatlantique SA purchased a new stake in shares of Docusign in the first quarter worth about $26,000. Summit Securities Group LLC purchased a new position in Docusign during the first quarter valued at approximately $34,000. Rise Advisors LLC increased its holdings in Docusign by 864.6% during the 1st quarter. Rise Advisors LLC now owns 463 shares of the company’s stock worth $38,000 after acquiring an additional 415 shares during the period. WPG Advisers LLC purchased a new stake in Docusign in the 1st quarter worth approximately $39,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Docusign in the 2nd quarter valued at $43,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on DOCU. Piper Sandler decreased their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Morgan Stanley boosted their target price on Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. Citigroup upped their target price on Docusign from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, September 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a research report on Wednesday, October 8th. Finally, UBS Group cut their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Four analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. Based on data from MarketBeat.com, Docusign currently has a consensus rating of “Hold” and a consensus price target of $86.71.

View Our Latest Stock Analysis on Docusign

Docusign Stock Up 1.3%

Shares of DOCU stock opened at $71.11 on Monday. The business has a 50-day moving average price of $69.18 and a two-hundred day moving average price of $74.52. Docusign Inc. has a 12-month low of $63.41 and a 12-month high of $99.71. The firm has a market cap of $14.24 billion, a P/E ratio of 49.73, a price-to-earnings-growth ratio of 3.57 and a beta of 0.98.

Insider Activity

In other news, CEO Allan C. Thygesen sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $69.69, for a total value of $2,787,600.00. Following the completion of the sale, the chief executive officer directly owned 136,246 shares in the company, valued at approximately $9,494,983.74. The trade was a 22.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the company’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total transaction of $790,197.90. Following the completion of the sale, the chief financial officer directly owned 112,160 shares of the company’s stock, valued at $9,320,496. This trade represents a 7.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 86,302 shares of company stock valued at $6,359,253. Insiders own 1.66% of the company’s stock.

Docusign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.